# Gut Microbiota Dysbiosis in Opioid Use Disorders: Implications for Clinical Symptoms and Relapse Rate.

> **NCT06231849** · — · UNKNOWN · sponsor: **Assiut University** · enrollment: 52 (estimated)

## Conditions studied

- Opioid Use
- Opioid Use Disorder
- Opioid Dependence

## Interventions

- **DIAGNOSTIC_TEST:** stool analysis

## Key facts

- **NCT ID:** NCT06231849
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-02
- **Primary completion:** 2026-02
- **Final completion:** 2026-04
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2024-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06231849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06231849, "Gut Microbiota Dysbiosis in Opioid Use Disorders: Implications for Clinical Symptoms and Relapse Rate.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06231849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*